Recurrent gram-negative bacteremia: Incidence and clinical patterns

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 611-617

  Wendt, Constanze ^a,b,c,d   Messer, Shawn A ^a,b,c   Hollis, Richard J ^a,b,c   Pfaller, Michael A ^a,b,c   Wenzel, Richard P ^a,b,c,e   Herwaldt, Loreen A ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION RATE; INFECTION SENSITIVITY; INTRAVENOUS CATHETER; PRIORITY JOURNAL; RECURRENT DISEASE; REINFECTION; RELAPSE; RISK FACTOR;

EID: 0033009674     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515152     Document Type: Article

References (26)

1. 1. Centers for Disease Control and Prevention. Advance report at final mortality statistic, 1990. Monthly Vital Stat Rep 1993;41(no. 7, supplement): 1-12.
2. 2. Centers for Disease Control. Increase in national hospital discharge survey rates for septicemia - United States, 1979-1987. MMWR Morb Mortal Wkly Rep 1990;39:31-4.
3. 3. Wenzel RP. Anti-endotoxin monoclonal antibodies - a second look. N Engl J Med 1992;326:1151-3.
4. 4. Bone RC. Gram-negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev 1993;6:57-68.
5. 5. Capdevila JA, Almirante B, Pahissa A, Planes AM, Ribera E, Martínez-Vázquez JM. Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch Intern Med 1994;154:411-5.
6. 6. Mylotte JM, McDermott C. Recurrent gram-negative bacteremia. Am J Med 1988;85:159-63.
7. 7. Maslow JN, Mulligan ME, Arbeit RD. Recurrent Escherichia coli bacteremia. J Clin Microbiol 1994;32:710-4.
8. 8. Weinstein MP, Reller LB. Clinical importance of "breakthrough" bacteremia. Am J Med 1984;76:175-80.
9. 9. Anderson ET, Young LS, Hewitt WL. Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia. Am J Med 1976;61: 493-7.
10. 10. Brauner A, Kaijser B, Kühn I. Recurrent Escherichia coli bacteremia - clinical characteristics and bacterial properties. J Infect 1994;28:49-57.
11. 11. Arbeit RD. Laboratory procedures for the epidemiologic analysis of microorganisms. In: Murray PR, Baron EJ, Pfaller MA, Tenover FL, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press, 1995:190-208.
12. 12. Miller PJ, Farr BM. Morbidity and mortality associated with multiple episodes of nosocomial bloodstream infection: a cohort study. Infect Control Hosp Epidemiol 1989;10:216-9.
13. 13. Wendt C, Messer SA, Hollis RJ, Pfaller MA, Wenzel RP, Herwaldt LA. Molecular epidemiology of gram-negative bacteremia. Clin Infect Dis 1999;28:605-10.
14. 14. McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962;110:847-55.
15. 15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
16. 16. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapy in sepsis. Crit Care Med 1992;20:864-73.
17. 17. Pfaller M, Hollis RJ, Sader HS. PFGE of chromosomal DNA. In: Isenberg HD, ed. Clinical microbiology procedures handbook. Washington, DC: American Society for Microbiology, 1992; section 10.5.c.
18. 18. Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983;5:35-53.
19. 19. Ziegler EJ, McCutchan JA, Fierer J, et al. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982;307:1225-30.
20. 20. Aube H, Milan C, Blettery B. Risk factors for septic shock in early management of bacteremia. Am J Med 1992;93:283-8.
21. 21. McGowan JE Jr, Barnes MW, Finland M. Bacteremia at the Boston City hospital: occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. J Infect Dis 1975;132:316-35.
22. 22. Young LS. Sepsis syndrome. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious disease. 4th ed. New York: Churchill Livingstone, 1995:690-705.
23. 23. Henderson DK. Bacteremia due to percutaneous intravascular devices. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease. 4th ed. New York: Churchill Livingstone, 1995: 2587-99.
24. 24. Prince A, Heller B, Levy J, Heird W. Management of fever in patients with central vein catheters. Pediatr Infect Dis 1986;5:20-4.
25. 25. Hartman GE, Shochat SJ. Management of septic complications associated with Silastic catheters in childhood malignancy. Pediatr Infect Dis 1987; 6:1042-7.
26. 26. Olson TA, Fischer GW, Lupo MC, et al. Antimicrobial therapy of Broviac catheter infections in pediatric hematology oncology patients. J Pediatr Surg 1987;22:839-42.